Evidence map›Paper›PMID 33613872›Full record

ArticleJournal of extracellular vesicles2020

Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study.

Ursula S Sandau, Erika Duggan, Xiao Shi, Sierra J Smith, Marilyn Huckans, William E Schutzer, Jennifer M Loftis, Aaron Janowsky, John P Nolan, Julie A Saugstad

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. The Dilution Paradox in Extracellular Vesicle Flow Cytometry.Journal of extracellular vesicles · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ursula S SandauDepartment of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA.ORCID 0000-0002-3646-7089
Erika DugganScintillon Institute San Diego California USA.ORCID 0000-0002-6969-9126
Xiao ShiVA Portland Health Care System Portland Oregon USA.ORCID 0000-0002-6944-9135
Sierra J SmithDepartment of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA.ORCID 0000-0003-4130-5831
Marilyn HuckansVA Portland Health Care System Portland Oregon USA.ORCID 0000-0003-3643-3281
William E SchutzerVA Portland Health Care System Portland Oregon USA.ORCID 0000-0003-1970-8845
Jennifer M LoftisVA Portland Health Care System Portland Oregon USA.ORCID 0000-0003-1773-9365
Aaron JanowskyVA Portland Health Care System Portland Oregon USA.ORCID 0000-0002-9221-3841
John P NolanScintillon Institute San Diego California USA.ORCID 0000-0001-5845-3764
Julie A SaugstadDepartment of Anesthesiology & Perioperative Medicine Oregon Health & Science University Portland Oregon USA.ORCID 0000-0002-2996-9611
Oregon Health & Science University · USScintillon Institute · US

Funding

Traditional Service Core [Translational Service Core (TSC)]P50DA018165 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JANOWSKY, AARON J. · 2006 to 2016
$13.0M
Neuroscience of Aging, Neurodegeneration and Alzheimer’s DiseaseT32AG055378 · NIA · OREGON HEALTH & SCIENCE UNIVERSITY · PI JACOB RABER, HENRYK F URBANSKI · 2018 to 2026
$4.3M
Validation of CD74 as a treatment target for methamphetamine use disorderU18DA052351 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HUCKANS, MARILYN, LOFTIS, JENNIFER M · 2020 to 2020
$199k
HCV and co-morbid alcohol use disorders: a translational investigation of antiviral therapy outcomes on CNS functionI01BX002061 · VA · PORTLAND VA MEDICAL CENTER · PI LOFTIS, JENNIFER M · 2014 to 2023
–
Cognitive Rehabilitation for Older Veterans with Mild Cognitive ImpairmentI01CX001592 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI O'NEIL, MAYA ELIN, TWAMLEY, ELIZABETH W · 2018 to 2024
–
BLRD VA I01 BX002061CSRD VA I01 CX001592NIA NIH HHS T32 AG055378NIDA NIH HHS P50 DA018165NIDA NIH HHS U18 DA052351
6 · The paper itself

Abstract

Methamphetamine (MA) is the largest drug threat across the globe, with health effects including neurotoxicity and cardiovascular disease. Recent studies have begun to link microRNAs (miRNAs) to the processes related to MA use and addiction. Our studies are the first to analyse plasma EVs and their miRNA cargo in humans actively using MA (MA-ACT) and control participants (CTL). In this cohort we also assessed the effects of tobacco use on plasma EVs. We used vesicle flow cytometry to show that the MA-ACT group had an increased abundance of EV tetraspanin markers (CD9, CD63, CD81), but not pro-coagulant, platelet-, and red blood cell-derived EVs. We also found that of the 169 plasma EV miRNAs, eight were of interest in MA-ACT based on multiple statistical criteria. In smokers, we identified 15 miRNAs of interest, two that overlapped with the eight MA-ACT miRNAs. Three of the MA-ACT miRNAs significantly correlated with clinical features of MA use and target prediction with these miRNAs identified pathways implicated in MA use, including cardiovascular disease and neuroinflammation. Together our findings indicate that MA use regulates EVs and their miRNA cargo, and support that further studies are warranted to investigate their mechanistic role in addiction, recovery, and recidivism.

Indexed as

AdultAmphetamine-Related DisordersBiomarkersCirculating MicroRNAExtracellular VesiclesFemaleFlow CytometryHumansMaleMethamphetamineMiddle AgedBiomarkersCirculating MicroRNAMethamphetamineaddictionextracellular vesiclemethamphetaminemicroRNAplasmatobaccovesicle flow cytometry

Identifiers

PMID33613872
PMCPMC7890470
OpenAlexW3107156369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.